Natalie Dean
#127,483
Most Influential Person Now
American biostatistician specializing in infectious disease epidemiology
Natalie Dean's AcademicInfluence.com Rankings
Natalie Deanmedical Degrees
Medical
#3530
World Rank
#4002
Historical Rank
Epidemiology
#740
World Rank
#772
Historical Rank
Natalie Deanmathematics Degrees
Mathematics
#7856
World Rank
#10666
Historical Rank
Statistics
#1079
World Rank
#1182
Historical Rank
Download Badge
Medical Mathematics
Natalie Dean's Degrees
- PhD Biostatistics Emory University
- Masters Biostatistics Emory University
- Bachelors Mathematics University of Georgia
Similar Degrees You Can Earn
Why Is Natalie Dean Influential?
(Suggest an Edit or Addition)According to Wikipedia, Natalie E. Dean is an American biostatistician specializing in infectious disease epidemiology. Dean is currently an assistant professor of Biostatistics at the University of Florida. Her research involves epidemiological modeling of outbreaks, including Ebola, Zika and COVID-19.
Natalie Dean's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!) (2017) (716)
- Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial (2015) (685)
- Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19 (2020) (532)
- Epidemiological and clinical features of the 2019 novel coronavirus outbreak in China (2020) (496)
- Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study (2020) (365)
- Household Transmission of SARS-CoV-2 (2020) (355)
- Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate (2020) (338)
- Spread of Zika virus in the Americas (2017) (252)
- Understanding COVID-19 vaccine efficacy (2020) (164)
- Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study (2021) (163)
- Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic (2020) (132)
- The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola (2015) (120)
- Household Secondary Attack Rate of COVID-19 and Associated Determinants (2020) (100)
- COVID-19 vaccine trials should seek worthwhile efficacy (2020) (95)
- Factors Associated With Household Transmission of SARS-CoV-2 (2021) (86)
- The changing epidemiology of SARS-CoV-2 (2022) (86)
- Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone (2016) (81)
- Covid-19 Vaccine Effectiveness and the Test-Negative Design (2021) (73)
- Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report (2017) (73)
- Preventing a Secondary Epidemic of Lost Early Career Scientists. Effects of COVID-19 Pandemic on Women with Children (2020) (72)
- Early childhood malnutrition predicts depressive symptoms at ages 11-17. (2010) (63)
- Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. (2016) (62)
- Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines (2021) (62)
- The public health value of vaccines beyond efficacy: methods, measures and outcomes (2017) (61)
- Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks. (2020) (59)
- Containing Ebola at the Source with Ring Vaccination (2016) (57)
- Household secondary attack rates of SARS-CoV-2 by variant and vaccination status: an updated systematic review and meta-analysis (2022) (51)
- The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016 (2016) (50)
- Malnutrition in the first year of life and personality at age 40. (2013) (45)
- Efficacy Estimates for Various COVID-19 Vaccines: What we Know from the Literature and Reports (2021) (43)
- Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status (2022) (42)
- Evaluating Confidence Interval Methods for Binomial Proportions in Clustered Surveys (2015) (42)
- Effectiveness of an Inactivated Covid-19 Vaccine with Homologous and Heterologous Boosters against the Omicron (B.1.1.529) Variant (2022) (42)
- Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study (2022) (40)
- Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave (2021) (38)
- Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis (2016) (36)
- Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas (2020) (35)
- Estimating the establishment of local transmission and the cryptic phase of the COVID-19 pandemic in the USA (2020) (34)
- Avian Influenza A Virus Infection among Workers at Live Poultry Markets, China, 2013–2016 (2018) (34)
- Design of vaccine efficacy trials during public health emergencies (2019) (34)
- Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials (2020) (30)
- Projected spread of Zika virus in the Americas (2016) (22)
- Effi cacy and eff ectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein : interim results from the Guinea ring vaccination cluster-randomised trial (2015) (20)
- Estimating the effect of cooperative versus uncooperative strategies of COVID-19 vaccine allocation: a modeling study (2020) (19)
- Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil (2022) (19)
- Use of recently vaccinated individuals to detect bias in test-negative case-control studies of COVID-19 vaccine effectiveness (2021) (19)
- SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy (2021) (18)
- COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance (2020) (18)
- The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico (2020) (12)
- Assessment of the World Health Organization’s HIV Drug Resistance Early Warning Indicators in Main and Decentralized Outreach Antiretroviral Therapy Sites in Namibia (2016) (11)
- RE: "MEASUREMENT OF VACCINE DIRECT EFFECTS UNDER THE TEST-NEGATIVE DESIGN". (2019) (11)
- Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015–2016 ZIKV epidemic (2018) (9)
- An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool (2019) (9)
- Challenges of evaluating and modelling vaccination in emerging infectious diseases (2021) (8)
- Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States (2021) (8)
- Aggregating data from COVID-19 trials (2020) (7)
- Effectiveness of CoronaVac, ChAdOx1, BNT162b2 and Ad26.COV2.S among individuals with prior SARS-CoV-2 infection in Brazil (2021) (7)
- Considerations for the design of vaccine efficacy trials during public health emergencies (2018) (6)
- DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR. (2018) (6)
- Temporal Confounding in the Test Negative Design. (2020) (6)
- Seroprevalence of Measles , Rubella , Mumps and Varicella Specific Antibodies in Primary School Children (2016) (6)
- The ring vaccination trial design for the estimation of vaccine efficacy and effectiveness during infectious disease outbreaks (2022) (4)
- SARS-CoV-2 shifting transmission dynamics and hidden reservoirs limited the efficacy of public health interventions in Italy (2020) (4)
- Protecting the herd with vaccination. (2022) (4)
- Provincial and National Prevalence Estimates of Transmitted HIV-1 drug Resistance in South Africa Measured using two WHO-recommended Methods (2019) (4)
- Estimating the risk of sustained community transmission of COVID-19 outside Mainland China (2020) (4)
- Change in COVID-19 risk over time following vaccination with CoronaVac: A testnegative case-control study (2021) (4)
- Guiding Vaccine Efficacy Trial Design During Public Health Emergencies: An interactive web-based decision support tool (2018) (3)
- The Usefulness of the Test-Positive Proportion of Severe Acute Respiratory Syndrome Coronavirus 2 as a Surveillance Tool (2021) (3)
- Effectiveness of Primary and Booster COVID-19 mRNA Vaccination against Infection Caused by the SARS-CoV-2 Omicron Variant in People with a Prior SARS-CoV-2 Infection (2022) (3)
- Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic (2021) (3)
- Hospital admissions due to COVID-19 in Scotland after one dose of vaccine (2021) (3)
- High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in Namibia (2020) (3)
- Ebola vaccination – Authors' reply (2015) (3)
- The usefulness of SARS-CoV-2 test positive proportion as a surveillance tool (2020) (2)
- Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study (2022) (2)
- Surveillance Methods for Monitoring HIV Incidence and Drug Resistance (2014) (2)
- Statistical successes and failures during the COVID‐19 pandemic: Comments on Ellenberg and Morris (2021) (2)
- COVID vaccination studies: plan now to pool data, or be bogged down in confusion (2021) (2)
- Using simulated infectious disease outbreaks to guide the design of individually randomized vaccine trials (2021) (1)
- Discussion of “Regression Models for Understanding COVID-19 Epidemic Dynamics With Incomplete Data” (2021) (1)
- Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study (2022) (1)
- Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysis (2022) (1)
- Use of Recently Vaccinated Individuals to Detect Bias in Test-Negative Case–Control Studies of COVID-19 Vaccine Effectiveness (2022) (1)
- Two-stage adaptive enrichment design for testing an active factor (2020) (0)
- Application of Phylodynamic Tools to Inform the Public Health Response to COVID-19: Qualitative Analysis of Expert Opinions (2022) (0)
- PNAS Plus Significance Statements (2017) (0)
- Supplementary Material: Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic (2020) (0)
- Epidemiology Temporal Confounding in the Test-Negative Design (2020) (0)
- Quantifying the risk of local Zika virus transmission in the continental US during the 2015-2016 ZIKV epidemic (2018) (0)
- Science Magazine (2008) (0)
- Design of Vaccine Trials during Outbreaks with and without a Delayed Vaccination Comparator (2016) (0)
- The prevalence of pre‐treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017–2018 (2022) (0)
- Factors Associated with the Transfer of Pediatric Patients with Supracondylar Humerus Fractures to a Level I Pediatric Trauma Center. (2014) (0)
- Projections of Zika spread in the Continental US (2016) (0)
- Covariate-constrained randomization with cluster selection and substitution. (2023) (0)
- SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy (2021) (0)
This paper list is powered by the following services:
Other Resources About Natalie Dean
What Schools Are Affiliated With Natalie Dean?
Natalie Dean is affiliated with the following schools:
